Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Quantifying the Financial Savings of Motion Correction in Brain MRI: A Model-Based Estimate of the Costs Arising From Patient Head Motion and Potential Savings From Implementation of Motion Correction.

Slipsager JM, Glimberg SL, Søgaard J, Paulsen RR, Johannesen HH, Martens PC, Seth A, Marner L, Henriksen OM, Olesen OV, Højgaard L.

J Magn Reson Imaging. 2020 Mar 7. doi: 10.1002/jmri.27112. [Epub ahead of print]

PMID:
32144848
2.

18F-FDG PET/MR-imaging in a Göttingen Minipig model of atherosclerosis: Correlations with histology and quantitative gene expression.

Ludvigsen TP, Pedersen SF, Vegge A, Ripa RS, Johannesen HH, Hansen AE, Löfgren J, Schumacher-Petersen C, Kirk RK, Pedersen HD, Christoffersen BØ, Ørbæk M, Forman JL, Klausen TL, Olsen LH, Kjaer A.

Atherosclerosis. 2019 Jun;285:55-63. doi: 10.1016/j.atherosclerosis.2019.04.209. Epub 2019 Apr 9.

PMID:
31004968
3.

Intratumor heterogeneity of PD-L1 expression in head and neck squamous cell carcinoma.

Rasmussen JH, Lelkaitis G, Håkansson K, Vogelius IR, Johannesen HH, Fischer BM, Bentzen SM, Specht L, Kristensen CA, von Buchwald C, Wessel I, Friborg J.

Br J Cancer. 2019 May;120(10):1003-1006. doi: 10.1038/s41416-019-0449-y. Epub 2019 Apr 10.

PMID:
30967647
4.

PET/DW-MRI for evaluating treatment in chronic hepatitis C patients.

Petersen RJ, Nielsen NS, Johannesen HH, Hansen AE, Jespersen S, Arnbjerg CJ, Löfgren J, Kjær MS, Clausen MR, Kjær A, Nielsen SD, Fischer BM.

Am J Nucl Med Mol Imaging. 2019 Feb 15;9(1):84-92. eCollection 2019.

5.

Phase contrast mapping MRI measurements of global cerebral blood flow across different perfusion states - A direct comparison with 15O-H2O positron emission tomography using a hybrid PET/MR system.

Puig O, Vestergaard MB, Lindberg U, Hansen AE, Ulrich A, Andersen FL, Johannesen HH, Rostrup E, Law I, Larsson HB, Henriksen OM.

J Cereb Blood Flow Metab. 2019 Dec;39(12):2368-2378. doi: 10.1177/0271678X18798762. Epub 2018 Sep 11.

6.

Components of day-to-day variability of cerebral perfusion measurements - Analysis of phase contrast mapping magnetic resonance imaging measurements in healthy volunteers.

Ismaili ARA, Vestergaard MB, Hansen AE, Larsson HBW, Johannesen HH, Law I, Henriksen OM.

PLoS One. 2018 Jun 7;13(6):e0197807. doi: 10.1371/journal.pone.0197807. eCollection 2018.

7.

Effect of Lactobacillus rhamnosus GG Supplementation on Intestinal Inflammation Assessed by PET/MRI Scans and Gut Microbiota Composition in HIV-Infected Individuals.

Arnbjerg CJ, Vestad B, Hov JR, Pedersen KK, Jespersen S, Johannesen HH, Holm K, Halvorsen B, Fallentin E, Hansen AE, Lange T, Kjær A, Trøseid M, Fischer BM, Nielsen SD.

J Acquir Immune Defic Syndr. 2018 Aug 1;78(4):450-457. doi: 10.1097/QAI.0000000000001693.

PMID:
29874201
8.

Combined hyperpolarized 13C-pyruvate MRS and 18F-FDG PET (hyperPET) estimates of glycolysis in canine cancer patients.

Hansen AE, Gutte H, Holst P, Johannesen HH, Rahbek S, Clemmensen AE, Larsen MME, Schøier C, Ardenkjaer-Larsen J, Klausen TL, Kristensen AT, Kjaer A.

Eur J Radiol. 2018 Jun;103:6-12. doi: 10.1016/j.ejrad.2018.02.028. Epub 2018 Feb 25.

9.

Ultra-early apparent diffusion coefficient change indicates irradiation and predicts radiotherapy outcome in brain metastases.

Mahmood F, Johannesen HH, Geertsen P, Hansen RH.

Acta Oncol. 2017 Nov;56(11):1651-1653. doi: 10.1080/0284186X.2017.1348627. Epub 2017 Aug 29. No abstract available.

PMID:
28849704
10.

Repeated diffusion MRI reveals earliest time point for stratification of radiotherapy response in brain metastases.

Mahmood F, Johannesen HH, Geertsen P, Hansen RH.

Phys Med Biol. 2017 Apr 21;62(8):2990-3002. doi: 10.1088/1361-6560/aa5249. Epub 2017 Mar 17.

PMID:
28306548
11.

Capecitabine and Oxaliplatin Before, During, and After Radiotherapy for High-Risk Rectal Cancer.

Larsen FO, Markussen A, Jensen BV, Fromm AL, Vistisen KK, Parner VK, Linnemann D, Hansen RH, Johannesen HH, Schou JV.

Clin Colorectal Cancer. 2017 Jun;16(2):e7-e14. doi: 10.1016/j.clcc.2016.07.020. Epub 2016 Sep 14.

PMID:
27743742
12.

Feasibility of Multiparametric Imaging with PET/MR in Head and Neck Squamous Cell Carcinoma.

Rasmussen JH, Nørgaard M, Hansen AE, Vogelius IR, Aznar MC, Johannesen HH, Costa J, Engberg AM, Kjær A, Specht L, Fischer BM.

J Nucl Med. 2017 Jan;58(1):69-74. doi: 10.2967/jnumed.116.180091. Epub 2016 Sep 8.

13.

In Vivo Phenotyping of Tumor Metabolism in a Canine Cancer Patient with Simultaneous (18)F-FDG-PET and Hyperpolarized (13)C-Pyruvate Magnetic Resonance Spectroscopic Imaging (hyperPET): Mismatch Demonstrates that FDG may not Always Reflect the Warburg Effect.

Gutte H, Hansen AE, Larsen MM, Rahbek S, Johannesen HH, Ardenkjaer-Larsen J, Kristensen AT, Højgaard L, Kjaer A.

Diagnostics (Basel). 2015 Jun 26;5(3):287-9. doi: 10.3390/diagnostics5030287.

14.

Simultaneous Hyperpolarized 13C-Pyruvate MRI and 18F-FDG PET (HyperPET) in 10 Dogs with Cancer.

Gutte H, Hansen AE, Larsen MM, Rahbek S, Henriksen ST, Johannesen HH, Ardenkjaer-Larsen J, Kristensen AT, Højgaard L, Kjær A.

J Nucl Med. 2015 Nov;56(11):1786-92. doi: 10.2967/jnumed.115.156364. Epub 2015 Sep 3.

15.

The effect of region of interest strategies on apparent diffusion coefficient assessment in patients treated with palliative radiation therapy to brain metastases.

Mahmood F, Johannesen HH, Geertsen P, Opheim GF, Hansen RH.

Acta Oncol. 2015;54(9):1529-34. doi: 10.3109/0284186X.2015.1061211. Epub 2015 Aug 3.

PMID:
26236963
16.

Simultaneous hyperpolarized (13)C-pyruvate MRI and (18)F-FDG-PET in cancer (hyperPET): feasibility of a new imaging concept using a clinical PET/MRI scanner.

Gutte H, Hansen AE, Henriksen ST, Johannesen HH, Ardenkjaer-Larsen J, Vignaud A, Hansen AE, Børresen B, Klausen TL, Wittekind AM, Gillings N, Kristensen AT, Clemmensen A, Højgaard L, Kjær A.

Am J Nucl Med Mol Imaging. 2014 Dec 15;5(1):38-45. eCollection 2015.

17.

Feasibility of simultaneous PET/MR in diet-induced atherosclerotic minipig: a pilot study for translational imaging.

Pedersen SF, Ludvigsen TP, Johannesen HH, Löfgren J, Ripa RS, Hansen AE, Ettrup AJ, Christoffersen BØ, Pedersen HD, Olsen LH, Højgaard L, Kjær A.

Am J Nucl Med Mol Imaging. 2014 Aug 15;4(5):448-58. eCollection 2014.

18.

Geometric distortions of diffusion weighted imaging of the head/neck in combined PET/MR: optimization of image acquisition and post-processing correction for oncology applications.

Hansen AE, Rasmussen J, Johannesen HH, Engberg AM, Andersen FL, Specht L, Kjaer A, Højgaard L, Beyer T, Fischer BM.

EJNMMI Phys. 2014 Jul;1(Suppl 1):A76. doi: 10.1186/2197-7364-1-S1-A76. No abstract available.

19.

Identification and characterization of human brown adipose tissue (BAT) content and metabolism in adults using [(18)F]-FDG PET/MR - a pilot study.

Johannesen HH, Löfgren J, Donkin I, Hansen AE, Loft A, Højgaard L, Kjær A.

EJNMMI Phys. 2014 Jul;1(Suppl 1):A68. doi: 10.1186/2197-7364-1-S1-A68. No abstract available.

20.

FDG PET scans as evaluation of clinical response to dendritic cell vaccination in patients with malignant melanoma.

Engell-Noerregaard L, Hendel HW, Johannesen HH, Alslev L, Svane IM.

Cancer Immunol Immunother. 2013 Jan;62(1):17-25. doi: 10.1007/s00262-012-1306-5. Epub 2012 Jun 22.

PMID:
22722450

Supplemental Content

Loading ...
Support Center